293 related articles for article (PubMed ID: 26170307)
21. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
[TBL] [Abstract][Full Text] [Related]
22. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
23. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
24. BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.
Dickinson GS; Akkoyunlu M; Bram RJ; Alugupalli KR
Ann N Y Acad Sci; 2015 Dec; 1362():57-67. PubMed ID: 25962322
[TBL] [Abstract][Full Text] [Related]
25. Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse.
Liu L; Allman WR; Coleman AS; Takeda K; Lin TL; Akkoyunlu M
Sci Rep; 2018 Jan; 8(1):1308. PubMed ID: 29358664
[TBL] [Abstract][Full Text] [Related]
26. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
27. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
28. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
[TBL] [Abstract][Full Text] [Related]
29. APRIL:TACI axis is dispensable for the immune response to rabies vaccination.
Haley SL; Tzvetkov EP; Lytle AG; Alugupalli KR; Plummer JR; McGettigan JP
Antiviral Res; 2017 Aug; 144():130-137. PubMed ID: 28619678
[TBL] [Abstract][Full Text] [Related]
30. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
31. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
32. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
33. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
34. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
Rickert RC; Jellusova J; Miletic AV
Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
[TBL] [Abstract][Full Text] [Related]
35. TACI Isoforms Regulate Ligand Binding and Receptor Function.
Garcia-Carmona Y; Ting AT; Radigan L; Athuluri Divakar SK; Chavez J; Meffre E; Cerutti A; Cunningham-Rundles C
Front Immunol; 2018; 9():2125. PubMed ID: 30333819
[TBL] [Abstract][Full Text] [Related]
36. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
37. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
[TBL] [Abstract][Full Text] [Related]
38. Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells.
Jacobs HM; Thouvenel CD; Leach S; Arkatkar T; Metzler G; Scharping NE; Kolhatkar NS; Rawlings DJ; Jackson SW
J Immunol; 2016 May; 196(9):3525-31. PubMed ID: 27022196
[TBL] [Abstract][Full Text] [Related]
39. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.
García-Castro A; Zonca M; Florindo-Pinheiro D; Carvalho-Pinto CE; Cordero A; Gutiérrez del Fernando B; García-Grande A; Mañes S; Hahne M; González-Suárez E; Planelles L
Carcinogenesis; 2015 May; 36(5):574-84. PubMed ID: 25750171
[TBL] [Abstract][Full Text] [Related]
40. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
